You are here: Industry Insights > gene therapy

News List

Novartis building out cell and gene therapy platform that'll lead the pack, CEO promises fiercepharma
January 09, 2019
Novartis' first-ever CAR-T cell therapy may have been hamstrung by early manufacturing problems, but the company still figures it can build a cell and gene therapy platform strong enough to deliver success not only with Kymriah but also a full "game board
Novartis building out cell and gene therapy platform that'll lead the pack, CEO promises fiercepharma
January 09, 2019
Novartis' first-ever CAR-T cell therapy may have been hamstrung by early manufacturing problems, but the company still figures it can build a cell and gene therapy platform strong enough to deliver success not only with Kymriah but also a full "game board
Orchard Therapeutics Highlights Recent Accomplishments and 2019 Strategic Priorities as a Global Leader in Gene Therapy b3cnewswire
January 08, 2019
Orchard Therapeutics (NASDAQ: ORTX), a leading commercial-stage biopharmaceutical company dedicated to transforming the lives of patients with serious and ......
Sofinnova, LSP lead $17M round for gene therapy player XyloCor fiercebiotech
December 29, 2018
XyloCor Therapeutics raised $17 million in its series A round to advance a gene therapy pipeline for cardiovascular disease. Its lead asset is a treatment for angina that is poised to enter the clinic in 2019....
GenSight rebuilds its case for LHON gene therapy, eyeing filing next year fiercebiotech
December 26, 2018
GenSight Biologics has reported new data from its phase 3 program for GS010, its gene therapy for an ultrarare eye disease, sparking another uptick in its share price....
Axovant buys more gene therapies, setting it up for a busy 2019 fiercebiotech
December 26, 2018
Axovant has licensed two gene therapies from the University of Massachusetts Medical School (UMMS). The deal accelerates Axovant’s evolution into a gene therapy specialist by....
Mergers Among Biotech Stocks Could Rise In 2019 firstwordpharma
December 25, 2018
According to analysts at RBC Capital Markets, Sarepta Therapeutics, Sage Therapeutics and Loxo Oncology are the most likely takeover targets among biotechnology firms in 2019, reported Investor's Business Daily. Sarepta is working on a gene therapy in a m
Mergers Among Biotech Stocks Could Rise In 2019 firstwordpharma
December 25, 2018
According to analysts at RBC Capital Markets, Sarepta Therapeutics, Sage Therapeutics and Loxo Oncology are the most likely takeover targets among biotechnology firms in 2019, reported Investor's Business Daily. Sarepta is working on a gene therapy in a m
Novartis offers to buy Kymriah manufacturer pharmaphorum
December 24, 2018
Following its success in the burgeoning area of CAR-T therapies, Novartis is looking to strengthen its cell and gene manufacturing capabilities by offering to acquire CDMO CellforCure, manufacturers of its CAR-T drug Kymriah.
Orchard Therapeutics and SIRION Biotech Announce Licensing Agreement to Enhance Gene Therapy Manufacturing Efficiency b3cnewswire
December 17, 2018
Orchard Therapeutics (NASDAQ: ORTX), a leading commercial-stage biopharmaceutical company dedicated to transforming the lives of patients with......

Previous page 1 2 3 4 5 6 7 8 9 10 ... 20 21 Next page